Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22844887 | 1.00 | TSHR (0.35) | TSHRCA1CA2CA4ALDH1A1 | |
| SCHEMBL24923170 | 0.85 | TDP1 (0.41) | TSHRCA1CA2CA4 | |
| SCHEMBL14465957 | 0.85 | CA1 (0.36) | CA1CA2CA4 | |
| SCHEMBL5436274 | 0.78 | — | — | |
| SCHEMBL23082583 | 0.78 | — | — | |
| SCHEMBL1192834 | 0.78 | — | — | |
| SCHEMBL23082584 | 0.78 | — | — | |
| SCHEMBL25133152 | 0.78 | — | — | |
| SCHEMBL4688269 | 0.78 | — | — | |
| SCHEMBL14574289 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200405874-A1 | METHODS OF PREPARING CELL-BINDING AGENT-DRUG CONJUGATES | IMMUNOGEN, INC. | 2020-12-31 | — | — | US | disclosed |
| US-9556229-B2 | Modification of peptides using a bis(thioether)arylbridge approach | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-01-31 | — | — | US | disclosed |
| EP-1524289-B1 | POLYMERIZABLE COMPOSITION, OPTICAL MATERIAL COMPRISING THE COMPOSITION AND METHOD FOR PRODUCING THE MATERIAL | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-09-16 | — | — | EP | disclosed |
| EP-1279692-B1 | OPTICAL PARTS AND SULFUR-CONTAINING POLY(THIO)ESTER (CO)POLYMER | MITSUI CHEMICALS INC (JP) | 2009-02-18 | — | — | EP | disclosed |
| EP-1388540-B1 | ACRYLIC ESTERS AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20070149639-A1 | Polymerizable composition, optical material comprising the composition and method for producing the material | HORIKOSHI HIROSHI | 2007-06-28 | — | — | US | disclosed |
| US-7008571-B2 | Optical component and sulfur-containing poly(thio)ester (co)polymer | MITSUI CHEMICALS, INC. (JP) | 2006-03-07 | — | — | US | disclosed |
| EP-1524289-A1 | POLYMERIZABLE COMPOSITION, OPTICAL MATERIAL COMPRISING THE COMPOSITION AND METHOD FOR PRODUCING THE MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-04-20 | — | — | EP | disclosed |
| US-6835844-B2 | Acrylic esters and use thereof | MITSUI CHEMICALS, INC. (JP) | 2004-12-28 | — | — | US | disclosed |
| US-20040254258-A1 | Polymerizable composition, optical material comprising the composition and method for producing the material | MITSUBISHI GAS CHEMICAL CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| US-20040102592-A1 | Acrylic esters and use thereof | MITSUI CHEMICALS, INC. (JP) | 2004-05-27 | — | — | US | disclosed |
| EP-1388540-A1 | ACRYLIC ESTERS AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2004-02-11 | — | — | EP | disclosed |
| US-20030204030-A1 | Optical parts and sulfur-containing poly (thio)ester (co)polymer | MITSUI CHEMICALS, INC. (JP) | 2003-10-30 | — | — | US | disclosed |
| EP-1279692-A1 | OPTICAL PARTS AND SULFUR-CONTAINING POLY(THIO)ESTER (CO)POLYMER | Mitsui Chemicals, Inc. (JP) | 2003-01-29 | — | — | EP | disclosed |
| US-3979369-A | DIENE POLYMER | MONSANTO COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3974163-A | VULCANIZATION INHIBITOR | MONSANTO COMPANY (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200405874-A1 | METHODS OF PREPARING CELL-BINDING AGENT-DRUG CONJUGATES | EPCAM, CD2BP2, XPA | TSHR 2222/4885CA1 293/4885CA2 1600/4885 |
| US-20040102592-A1 | Acrylic esters and use thereof | RPS4Y1, EPB41, RPS4X | TSHR 4398/4885CA1 3337/4885CA2 3854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.